As two privately held companies with over a decade of experience, we combine strengths to deliver greater value. BioNukleo provides a portfolio of 70+ specialized enzymes proven for tailored nucleoside/nucleotide synthesis, while Enzymicals transforms proof-of-concept reactions into kilogram-scale processes. This non-exclusive partnership, facilitated by proximity in Greifswald and Berlin, provides an unparalleled advantage to clients, bridging innovative enzyme solutions with industrial-relevant implementation.
Together, we aim to set new standards in sustainable biocatalysis.
